New computer tool aims to boost HIV prevention in community clinics

NCT ID NCT05245201

Ongoing Knowledge-focused Sponsor: Harvard Pilgrim Health Care Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether an electronic health record tool can help doctors identify patients at higher risk for HIV and prescribe PrEP, a daily pill that prevents HIV. Researchers will roll out the tool in 2-3 community health centers and compare PrEP prescription rates to 2 clinics providing usual care. The study involves about 60 healthcare providers and focuses on feasibility and acceptability, not patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EHR-based clinical decision support tool
What this could lead to: If successful, this could lead to a larger trial that helps doctors better identify who might benefit from HIV prevention medication, potentially reducing new HIV infections.
What could go wrong: This is a very small pilot study with only 4 clinics, so results may not apply broadly. The tool may not change prescribing habits or may be difficult for providers to use consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS PREEXPOSURE PROPHYLAXIS (PREP)

Contacts and locations

Locations

Kintegra Health

Gastonia, North Carolina, 28052, United States
Roanoke Chowan Community Health Center

Ahoskie, North Carolina, 27910, United States
Saban Community Clinic

Los Angeles, California, 90038, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.